The SAI Difference
SAI is a full service agency partner providing tactical support across the brand lifecycle, with a unique focus on specialty therapeutics and the market access landscape.
- Leveraging best-in-class payer, distribution, & access influencer strategies
- Translating key customer insights into meaningful value propositions
- Integrating deep clinical & economic expertise of oncology and specialty therapeutic areas
- Driving optimal access through cost-effective, smart targeted marketing programs
What We Deliver
Specialty Access International is the agency arm of The Dedham Group, a specialized boutique management and strategy consulting company that offers a strong focus in the Oncology and Specialty Therapeutics space.
SAI’s winning Account Services team works to guide strategic development and tactical execution, while supporting our clients’ range of needs.
SAI’s Scientific Communications team generates insightful, relevant and scientific content that informs brand strategy.
SAI’s Creative Services team delivers progressive tactical solutions to communicate brand needs through compelling user experience, design, and execution.
Who We Target
- SAI offers a breadth of creative solutions to engage the range of access stakeholders.
- Account Team
- Specialty Pharmacy
- Provider Offices
What Our Clients Say
"SAI is unique among Access Agencies in that they bring the strategic expertise of The Dedham Group combined with the advantages of working with a high-touch, focused agency. SAI consistently brought me good strategic ideas and their project management expertise stood out as they leveraged their extensive knowledge of our internal processes to effectively and efficiently drive projects to completion."
"Few (payer) medical & pharmacy directors come from oncology, which is why we like working with TGD and SAI. We don’t have to spend any time educating ‘the agency’ instead of implementing…TDG and SAI connect the dots at a high level, & deliver."
"As the agency arm for The Dedham Group, SAI understands the strategic nuances of immunology and oncology access, & distribution."
“I was happy with the final product and the team was very receptive...hopefully, we can leverage it in other areas of the business.”